Optimising Clinical Development in Oncology
Venue: Le Meridien Piccadilly
|Event Date/Time: Apr 26, 2010||End Date/Time: Apr 28, 2010|
However, oncology poses unique patient recruitment, trial design and operational challenges â€“ issues that can waste invaluable resource and slow regulatory approval.
Through a series of interactive presentations and discussions, Pharma IQâ€™s Optimising Clinical Development in Oncology conference provides a unique platform for manufacturers to discuss practical, proven ideas to save time and money and ensure that companies have the knowledge they need to take their drugs to market fast.
This is the must-attend event for all clinical operations and clinical research executives in oncology practices and will feature industry-led keynotes, interactive panels, workshops, and a key emphasis on networking.
Why do you need to attend Optimising Clinical Development in Oncology?
â€¢ You will hear proven processes to overcome strategic and operational challenges to reduce costs and timelines during oncology trials
â€¢ You will learn how to improve your patient selection and retention strategies through a better understanding of trial goals and ideal patient populations
â€¢ You will participate in expert led interactive roundtable discussions to provide you with practical tools to ensure that your trials run smoothly
â€¢ You will get ideas on clinical trial partner selection and vendor management processes to maximize the return on your outsourcing investment
â€¢ Youâ€™ll learn how to improve your long-term outsourcing strategies to overcome clinical trial challenges in the current economic climate
â€¢ Youâ€™ll be able to take away ideas on managing the transition from early to late phase trials to ensure that your studies remain on target to achieve their goals
â€¢ You will hear about how your peers develop more robust processes for data capture and analysis to facilitate the use of adaptive trial models
â€¢ You will learn how to make the best use of biomarkers and imaging throughout your trial to better understand patient outcomes